Citigroup's Daniel Grosslight lifted McKesson to Buy with a $1,000 price target. That is up sharply from $945. The drug distributor carries a $98 billion market cap. Grosslight also upgraded Cardinal Health to Buy, raising the target to $265 from $245.
On the rails, Citi's Ariel Rosa boosted targets across the board. Union Pacific got a Buy with a $349 target, up from $326. Norfolk Southern and CSX also saw target lifts, though both stay at Hold. The moves suggest Citi sees improving freight conditions ahead.
In tech, Dell Technologies analysts pushed consensus targets to $503 from $489. Hewlett Packard Enterprise targets nudged up to $64.34. Both names are riding AI infrastructure spending.
Analysts slashed targets across the utility sector. Duke Energy, Xcel Energy, FirstEnergy, Entergy, and Southern Company all saw downward target revisions. The cuts were small in dollar terms but reflect pressure from rising rates.
DexCom received a new analyst recommendation. The glucose monitoring firm has a consensus target of $86.12 and a $27.6 billion market cap.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
